CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Ingenol mebutate

Last Updated: May 9, 2013
Result type: Reports
Project Number: SR0330-000
Product Line: Reimbursement Review

Generic Name: Ingenol mebutate

Brand Name: Picato

Manufacturer: LEO Pharma Inc.

Therapeutic Area: Actinic keratosis

Indications: Keratosis, actinic

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: January 22, 2014

Recommendation Type: Do not list